1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Wilex, Inc. - Medical Equipment - Deals and Alliances Profile

Summary

WILEX Inc. (Wilex) is a biopharmaceutical company. It manufactures, markets and sells companion diagnostic biomarker tests for targeted therapies. The company's product portfolio consists of in vitro diagnostic tests scuh as, HER-2/neu ELISA, CA IX IHC Kit, CA IX ELISA, EGFr ELISA, uPA ELISA, PAI-1 ELISA, TIMP-1 ELISA and their controls. It commercializes these diagnostic tests under the Oncogene Science brand name. Wilex also offers contract ELISA manufacturing services in the areas of automated plate coating, reagent bulk preparations and filling, and lyophilization. It operates a GMP and ISO certified manufacturing site. WILEX Inc. is a wholly owned US subsidiary of WILEX AG. WILEX Inc. is headquartered in Cambridge, Massachusetts, the US.

The company plans to expand its distribution network in Germany. This intent is visible as it recently entered into an agreement with Immundiagnostik AG for the distribution of its serum HER-2/neu and CA IX ELISA tests in Germany.

Wilex, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Wilex, Inc. - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Wilex, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 5
Wilex, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 6
Wilex, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 7
Wilex, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 8
Wilex, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 9
Wilex, Inc., Medical Equipment, Deal Details 10
Asset Purchase 10
Wilex Acquires Oncogene Science Assets From Siemens Healthcare Diagnostics 10
Partnerships 12
Wilex And Nuclea Biotechnologies Enter Into Agreement For Serum HER-2/Neu ELISA Test 12
Wilex Enters Into Co-Marketing Agreement With Immuno-Biological Labs For Portfolio Of Biomarker Tests 13
Wilex Enters Into Distribution Agreement With GeneDiagnostics For Serum HER-2/neu Test 14
WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 15
Acquisition 16
Nuclea Biotechnologies Acquires Wilex 16
Wilex, Inc. - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables

Wilex, Inc., Medical Equipment, Key Facts 1
Wilex, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 1
Wilex, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 5
Wilex, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 6
Wilex, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 7
Wilex, Inc., Deals By Market, 2009 to YTD 2015 8
Wilex, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 9
Wilex Acquires Oncogene Science Assets From Siemens Healthcare Diagnostics 10
Wilex And Nuclea Biotechnologies Enter Into Agreement For Serum HER-2/Neu ELISA Test 12
Wilex Enters Into Co-Marketing Agreement With Immuno-Biological Labs For Portfolio Of Biomarker Tests 13
Wilex Enters Into Distribution Agreement With GeneDiagnostics For Serum HER-2/neu Test 14
WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 15
Nuclea Biotechnologies Acquires Wilex 16
Wilex, Inc., Key Competitors 17
Wilex, Inc., Key Employees 18

List of Figures

Wilex, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 1
Wilex, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 1
Wilex, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 1
Wilex, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 1
Wilex, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 5
Wilex, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 6
Wilex, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 7
Wilex, Inc., Medical Equipment, Deals by Market, 2009 to YTD 2015 8

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
3D Cell Culture Technologies Patent Landscape

3D Cell Culture Technologies Patent Landscape

  • $ 5489
  • Company report
  • September 2016
  • by KnowMade

IP landscape for 3D cell culture technologies offers an important space to big entities as well as for small companies 3D CELL CULTURE : REPRODUCING AN IN VIVO-LIKE ENVIRONMENT IN VITRO The patent landscape ...

Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016

Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glucose Dependent Insulinotropic Receptor (G Protein ...

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Plasminogen Activator Inhibitor 1 (Endothelial ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.